Delivery Order SPE2DR25D3101-SPE2DR26F5S72
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $3,357.88 to AmerisourceBergen Drug Corp for Celebrex 200 mg capsules (100 unit doses) on December 11, 2025, with an ultimate completion date of December 12, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The product...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Celebrex 200 mg capsules in quantities of 100 units at a firm fixed price of $2,802.30. This contract represents a non-competitive delivery order without set-aside designation, with an ultimate completion date of August 14, 2025. The place of performance is listed as the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery...
- This federal contract award, valued at $4,969.60, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of CELEBREX 100 MG CAPSULE 100S, a pharmaceutical product, with a completion date of May 21, 2024. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,597.37 firm fixed-price delivery order is for the supply of Celecoxib 200 mg capsules, a medication used to treat pain and inflammation. The contract has an ultimate completion date of August 23, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,197.61, is for the delivery of 4,562,868,648 capsules of the medication Celecoxib 200 mg. This is a firm fixed-price delivery order contract with an ultimate completion date of November 21, 2023. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen...
- This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,714.56 firm fixed-price delivery order is for the supply of Celecoxib 200mg tablets, a pharmaceutical product. The contract has no set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award is a delivery order issued to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., by the Defense Logistics Agency (DLA). The contract is for the delivery of 4,563,043,087 units of the medication Celecoxib 200 mg Capsule, with a total ceiling value of $1,103.10. The contract is a firm fixed-price delivery order with a period of performance through December 11, 2023. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,129.50 delivery order covers the supply of CELEBREX 200 MG CAPSULE UD 100S, a pharmaceutical product. The award is part of a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA Troop Support Medical, valued at up to $999,999,999 and running through November 2026. This IDC serves as the primary vehicle for...
- The Defense Logistics Agency awarded a $127,620 delivery order to Amerisourcebergen Drug Corporation for 500 capsules of the pharmaceutical Celecoxib. As the prime contractor, Amerisourcebergen will deliver the medication from its facility in Conshohocken, Pennsylvania to fulfill DLA's requirements by September 25, 2023. A subsidiary of Amerisourcebergen Corporation, the prime contractor will perform under a firm fixed-price contract to supply the analgesic to the DLA, the agency that oversees...
- The Defense Logistics Agency awarded a $30,880 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 500 capsules of the drug celecoxib. The order is to be fulfilled by Amerisourcebergen's Corporate Office Division facility located in Conshohocken, Pennsylvania, with work to be completed between September 8-11, 2023. No set aside designation or subcontractors were identified. The Defense Logistics Agency manages the global supply chain for the United States Department of...
- SPE2DR25D3101Indefinite Delivery Contract
- SPE2DR25D3101-SPE2DR26F5S72Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,081.52 to AmerisourceBergen Drug Corp for Celebrex 200 mg capsules (100-count unit dose packaging). This non-set-aside contract was awarded on December 11, 2025, with an ultimate completion date of December 12, 2025, under firm fixed-price terms. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract issued under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor serving federal medical procurement needs, AmerisourceBergen supplies a comprehensive range of medications to military and veteran healthcare systems through DLA's Medical Supply Chain. The Celebrex order exemplifies the company's role in providing essential pharmaceuticals across multiple therapeutic domains to support Defense Health Agency operations and other federal healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 12/10/25 |